Advertisement

Internal and Emergency Medicine

, Volume 14, Issue 1, pp 71–76 | Cite as

Risk of new-onset atrial fibrillation among heart, kidney and liver transplant recipients: insights from a national cohort study

  • Wei-Syun HuEmail author
  • Cheng-Li Lin
IM - ORIGINAL
  • 44 Downloads

Abstract

The objective of the study was to explore the incidence of atrial fibrillation (AF) in various populations of patients with organ transplantation (OT). We used a large national data set from Taiwan to investigate the incidence of AF after OT. Frequency matching method used to match controls: OT patients were 4:1. Kaplan–Meier analyses with the use of the Aalen–Johansen estimator was employed for estimating the cumulative incidences of new-onset AF. The Fine–Gray competing risks model was also employed to analyze the risk of AF for the OT cohort compared with the non-OT cohort. 6955 OT patients and 27,820 controls were included in this study. OT did lead to a 3.09-fold risk for AF [95% confidence interval (CI) = 2.07–4.62], especially in the subgroup of female gender [adjusted subhazard ratio (aSHR) = 6.66, 95% CI = 3.85–11.5], age ≤ 49 years (aSHR = 8.19, 95% CI = 3.99–16.8) and without comorbidity (aSHR = 4.61, 95% CI = 2.71–7.87). Moreover, liver recipients tended to be more likely to develop new-onset AF among those OT patients (aSHR = 4.07, 95% CI = 2.63–6.30) as compared to the controls. This study demonstrates an increased incidence of AF after OT. Heightened awareness and clinician vigilance are warranted to facilitate early diagnosis and improved outcomes.

Keywords

Atrial fibrillation Cohort Competing risk analysis Organ transplantation 

Notes

Acknowledgements

This study was supported in part by the Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW107-TDU-B-212-123004).

Compliance with ethical standards

Conflict of interest

The author(s) declare that they have no conflict of interest

Statement of human and animal rights

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

None.

References

  1. 1.
    Health Resources and Services Administration: Organ procurement and transplant network database (2013). Available at. http://optn.transplant.hrsa.gov/. Accessed 20 Oct 2013
  2. 2.
    Bertoux F, On behalf of the EBPG Expert Group on Renal Transplantation (2002) European best practice guidelines on renal transplantation. Part 2. Nephrol Dial Transplant 17(Suppl 4):1–67Google Scholar
  3. 3.
    Lindenfeld J, Miller GG, Shakar SF, Zolty R, Lowes BD, Wolfel EE, Mestroni L, Page RL 2nd, Kobashigawa J (2004) Drug therapy in the heart transplant recipient. Part I: cardiac rejection and immunosuppressive drugs. Circulation 110(24):3734–3740CrossRefGoogle Scholar
  4. 4.
    American Society of Transplantation (2001) In: Norman DJ, Turka LA (eds) Primer on transplantation, vol 2. Wiley, New York, p 732Google Scholar
  5. 5.
    Busuttil RW (2005) In: Busuttil W, Klintmalm GB (eds) Transplantation of the liver, vol 2. Sounders, Philadelphia, p 1485Google Scholar
  6. 6.
    Xia VW, Worapot A, Huang S, Dhillon A, Gudzenko V, Backon A, Agopian VG, Aksoy O, Vorobiof G, Busuttil RW, Steadman RH (2015) Postoperative atrial fibrillation in liver transplantation. Am J Transplant 15(3):687–694CrossRefGoogle Scholar
  7. 7.
    Lentine KL, Schnitzler MA, Abbott KC, Li L, Xiao H, Burroughs TE, Takemoto SK, Willoughby LM, Gavard JA, Brennan DC (2006) Incidence, predictors, and associated outcomes of atrial fibrillation after kidney transplantation. Clin J Am Soc Nephrol 1(2):288–296CrossRefGoogle Scholar
  8. 8.
    Abbott KC, Reynolds JC, Taylor AJ, Agodoa LY (2003) Hospitalized atrial fibrillation after renal transplantation in the United States. Am J Transplant 3(4):471–476CrossRefGoogle Scholar
  9. 9.
    Thajudeen A, Stecker EC, Shehata M, Patel J, Wang X, McAnulty JH Jr, Kobashigawa J, Chugh SS (2012) Arrhythmias after heart transplantation: mechanisms and management. J Am Heart Assoc 1(2):e001461CrossRefGoogle Scholar
  10. 10.
    Pavri BB, O’Nunain SS, Newell JB, Ruskin JN, William G (1995) Prevalence and prognostic significance of atrial arrhythmias after orthotopic cardiac transplantation. J Am Coll Cardiol 25(7):1673–1680CrossRefGoogle Scholar
  11. 11.
    Fine JP, Gray RJ (1999) A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94:496–509CrossRefGoogle Scholar
  12. 12.
    Database NHIR (2007) Taiwan. http://nhird.nhri.org.tw/en/index.html. Accessed 10 May 2017
  13. 13.
    Hu WS, Lin CL (2017) Comparison of CHA2DS2-VASc, CHADS2 and HATCH scores for the prediction of new-onset atrial fibrillation in cancer patients: a nationwide cohort study of 760,339 study participants with competing risk analysis. Atherosclerosis 266:205–211CrossRefGoogle Scholar
  14. 14.
    Hu WS, Lin CL (2018) CHA2DS2-VASc score for prediction of ischemic stroke in patients with systemic lupus erythematosus without atrial fibrillation. Lupus 27(8):1240–1246CrossRefGoogle Scholar
  15. 15.
    Gooley TA, Leisenring W, Crowley J, Storer BE (1999) Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 18(6):695–706CrossRefGoogle Scholar
  16. 16.
    January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW, American College of Cardiology/American Heart Association Task Force on Practice Guidelines (2014) 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 64(21):e1–e76CrossRefGoogle Scholar
  17. 17.
    Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, Hindricks G, Kirchhof P, ESC Committee for Practice Guidelines (CPG) (2012) 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 33(21):2719–2747CrossRefGoogle Scholar
  18. 18.
    Cheng CL, Lee CH, Chen PS, Li YH, Lin SJ, Yang YH (2014) Validation of acute myocardial infarction cases in the national health insurance research database in Taiwan. J Epidemiol 24(6):500–507CrossRefGoogle Scholar
  19. 19.
    Cheng CL, Chien HC, Lee CH, Lin SJ, Yang YH (2015) Validity of in-hospital mortality data among patients with acute myocardial infarction or stroke in National Health Insurance Research Database in Taiwan. Int J Cardiol 15(201):96–101CrossRefGoogle Scholar

Copyright information

© Società Italiana di Medicina Interna 2018

Authors and Affiliations

  1. 1.School of Medicine, College of MedicineChina Medical UniversityTaichungTaiwan
  2. 2.Division of Cardiovascular Medicine, Department of MedicineChina Medical University HospitalTaichungTaiwan
  3. 3.Management Office for Health DataChina Medical University HospitalTaichungTaiwan

Personalised recommendations